Mirae Asset Global Investments’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,657,557
| Closed | -$1.47M | – | 2622 |
|
|
2022
Q4 | $1.47M | Buy |
1,657,557
+146,776
| +10% | +$130K | ﹤0.01% | 1299 |
|
|
2022
Q3 | $2.37M | Buy |
1,510,781
+175,710
| +13% | +$276K | 0.01% | 1067 |
|
|
2022
Q2 | $2.68M | Buy |
1,335,071
+429,224
| +47% | +$863K | 0.01% | 1048 |
|
|
2022
Q1 | $2.11M | Sell |
905,847
-149,396
| -14% | -$348K | ﹤0.01% | 1146 |
|
|
2021
Q4 | $4.91M | Buy |
1,055,243
+268,257
| +34% | +$1.25M | 0.01% | 890 |
|
|
2021
Q3 | $6.01M | Buy |
786,986
+154,327
| +24% | +$1.18M | 0.02% | 789 |
|
|
2021
Q2 | $6.13M | Buy |
632,659
+126,084
| +25% | +$1.22M | 0.02% | 767 |
|
|
2021
Q1 | $4.19M | Buy |
506,575
+231,840
| +84% | +$1.92M | 0.01% | 768 |
|
|
2020
Q4 | $1.88M | Buy |
274,735
+144,342
| +111% | +$985K | 0.01% | 950 |
|
|
2020
Q3 | $1.45M | Buy |
130,393
+41,683
| +47% | +$465K | 0.01% | 861 |
|
|
2020
Q2 | $557K | Buy |
88,710
+45,588
| +106% | +$286K | ﹤0.01% | 1104 |
|
|
2020
Q1 | $79K | Buy |
43,122
+4,813
| +13% | +$8.82K | ﹤0.01% | 1390 |
|
|
2019
Q4 | $129K | Sell |
38,309
-11,482
| -23% | -$38.7K | ﹤0.01% | 1455 |
|
|
2019
Q3 | $107K | Buy |
49,791
+36,801
| +283% | +$79.1K | ﹤0.01% | 1410 |
|
|
2019
Q2 | $35K | Buy |
+12,990
| New | +$35K | ﹤0.01% | 1385 |
|